US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist
  • 13.185
  • -0.615-4.46%
Trading Dec 13 12:40 ET
339.88MMarket Cap-11.74P/E (TTM)

Contineum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-14.73%-6.17M
-120.90%-8.5M
-52.08%-7.98M
196.16%19.35M
-162.61%-10.7M
-5.38M
40.67M
-5.24M
23.40%-20.12M
-4.08M
Net income from continuing operations
-64.25%-10.27M
-121.68%-9.01M
-74.48%-8.42M
193.68%22.72M
-3.42%-7.77M
---6.25M
--41.56M
---4.82M
16.37%-24.25M
---7.51M
Operating gains losses
----
----
387.50%117K
300.00%14K
-166.67%-8K
---2K
--0
--24K
-250.00%-7K
---3K
Depreciation and amortization
44.19%62K
42.86%60K
-16.44%61K
-40.73%195K
-54.32%37K
--43K
--42K
--73K
1.23%329K
--81K
Other non cash items
-1.28%231K
112.26%351K
-7.58%244K
-172.46%-2.1M
-89.65%265K
--234K
---2.86M
--264K
1,667.07%2.9M
--2.56M
Change In working capital
107.15%2.32M
-112.58%-209K
127.12%275K
19.18%-1.02M
-765.87%-2.79M
--1.12M
--1.66M
---1.01M
-1,273.15%-1.27M
--419K
-Change in prepaid assets
135.11%435K
189.13%133K
1,288.33%713K
-237.83%-1.28M
-131.17%-24K
---1.24M
--46K
---60K
-0.53%-378K
--77K
-Change in payables and accrued expense
-30.26%1.87M
-170.16%-1.29M
35.34%-450K
2,244.12%1.59M
-450.63%-2.23M
--2.68M
--1.84M
---696K
-80.90%68K
--636K
-Change in other current assets
101.67%1K
3,127.59%936K
--0
121.88%7K
203.13%33K
---60K
--29K
--5K
-300.00%-32K
---32K
-Change in other current liabilities
104.96%13K
105.12%13K
104.56%12K
-45.73%-1.35M
19.63%-569K
---262K
---254K
---263K
-925.89%-925K
---708K
Cash from discontinued investing activities
Operating cash flow
-14.73%-6.17M
-120.90%-8.5M
-52.08%-7.98M
196.16%19.35M
-162.55%-10.7M
---5.38M
--40.67M
---5.24M
23.40%-20.12M
---4.08M
Investing cash flow
Cash flow from continuing investing activities
23.58%-30.18M
12.50%-38.9M
-6.67%8.73M
-394.04%-65.57M
83.65%9.03M
-39.5M
-44.46M
9.36M
134.32%22.3M
4.92M
Net PPE purchase and sale
-181.82%-62K
-283.87%-119K
-182.69%-147K
-250.85%-414K
---309K
---22K
---31K
---52K
29.76%-118K
--0
Net investment purchase and sale
23.69%-30.12M
12.71%-38.78M
-5.62%8.88M
-390.65%-65.15M
89.93%9.34M
---39.47M
---44.43M
--9.41M
134.59%22.42M
--4.92M
Cash from discontinued investing activities
Investing cash flow
23.58%-30.18M
12.50%-38.9M
-6.67%8.73M
-394.04%-65.57M
83.65%9.03M
---39.5M
---44.46M
--9.36M
134.32%22.3M
--4.92M
Financing cash flow
Cash flow from continuing financing activities
-99.87%13K
131.60%108.36M
97.08%-18K
4,633.98%56.18M
48.64%-321K
10.33M
46.79M
-617K
-101.55%-1.24M
-625K
Net issuance payments of debt
--0
--0
--0
-200.00%-3.75M
--0
--0
---3.13M
---625K
---1.25M
---625K
Net common stock issuance
--0
----
----
-600.00%-28K
---28K
--0
----
----
---4K
--0
Net preferred stock issuance
--0
----
----
--60.14M
--0
--10.24M
----
----
--0
--0
Proceeds from stock option exercised by employees
-84.15%13K
-31.58%13K
1,425.00%122K
960.00%159K
--50K
--82K
--19K
--8K
-86.73%15K
--0
Net other financing activities
----
----
---140K
---343K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-99.87%13K
131.60%108.36M
97.08%-18K
4,633.98%56.18M
48.64%-321K
--10.33M
--46.79M
---617K
-101.55%-1.24M
---625K
Net cash flow
Beginning cash position
48.32%77.23M
79.45%16.26M
178.79%15.53M
20.28%5.57M
227.25%17.52M
--52.07M
--9.06M
--5.57M
-71.11%4.63M
--5.35M
Current changes in cash
-5.18%-36.34M
41.76%60.97M
-78.88%738K
960.38%9.96M
-1,027.91%-2M
---34.55M
--43.01M
--3.49M
108.24%939K
--215K
End cash Position
133.38%40.89M
48.32%77.23M
79.45%16.26M
178.79%15.53M
178.79%15.53M
--17.52M
--52.07M
--9.06M
20.28%5.57M
--5.57M
Free cash flow
-15.78%-6.25M
-121.20%-8.62M
-53.36%-8.12M
193.56%18.94M
-170.13%-11.01M
---5.4M
--40.64M
---5.3M
23.44%-20.24M
---4.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -14.73%-6.17M-120.90%-8.5M-52.08%-7.98M196.16%19.35M-162.61%-10.7M-5.38M40.67M-5.24M23.40%-20.12M-4.08M
Net income from continuing operations -64.25%-10.27M-121.68%-9.01M-74.48%-8.42M193.68%22.72M-3.42%-7.77M---6.25M--41.56M---4.82M16.37%-24.25M---7.51M
Operating gains losses --------387.50%117K300.00%14K-166.67%-8K---2K--0--24K-250.00%-7K---3K
Depreciation and amortization 44.19%62K42.86%60K-16.44%61K-40.73%195K-54.32%37K--43K--42K--73K1.23%329K--81K
Other non cash items -1.28%231K112.26%351K-7.58%244K-172.46%-2.1M-89.65%265K--234K---2.86M--264K1,667.07%2.9M--2.56M
Change In working capital 107.15%2.32M-112.58%-209K127.12%275K19.18%-1.02M-765.87%-2.79M--1.12M--1.66M---1.01M-1,273.15%-1.27M--419K
-Change in prepaid assets 135.11%435K189.13%133K1,288.33%713K-237.83%-1.28M-131.17%-24K---1.24M--46K---60K-0.53%-378K--77K
-Change in payables and accrued expense -30.26%1.87M-170.16%-1.29M35.34%-450K2,244.12%1.59M-450.63%-2.23M--2.68M--1.84M---696K-80.90%68K--636K
-Change in other current assets 101.67%1K3,127.59%936K--0121.88%7K203.13%33K---60K--29K--5K-300.00%-32K---32K
-Change in other current liabilities 104.96%13K105.12%13K104.56%12K-45.73%-1.35M19.63%-569K---262K---254K---263K-925.89%-925K---708K
Cash from discontinued investing activities
Operating cash flow -14.73%-6.17M-120.90%-8.5M-52.08%-7.98M196.16%19.35M-162.55%-10.7M---5.38M--40.67M---5.24M23.40%-20.12M---4.08M
Investing cash flow
Cash flow from continuing investing activities 23.58%-30.18M12.50%-38.9M-6.67%8.73M-394.04%-65.57M83.65%9.03M-39.5M-44.46M9.36M134.32%22.3M4.92M
Net PPE purchase and sale -181.82%-62K-283.87%-119K-182.69%-147K-250.85%-414K---309K---22K---31K---52K29.76%-118K--0
Net investment purchase and sale 23.69%-30.12M12.71%-38.78M-5.62%8.88M-390.65%-65.15M89.93%9.34M---39.47M---44.43M--9.41M134.59%22.42M--4.92M
Cash from discontinued investing activities
Investing cash flow 23.58%-30.18M12.50%-38.9M-6.67%8.73M-394.04%-65.57M83.65%9.03M---39.5M---44.46M--9.36M134.32%22.3M--4.92M
Financing cash flow
Cash flow from continuing financing activities -99.87%13K131.60%108.36M97.08%-18K4,633.98%56.18M48.64%-321K10.33M46.79M-617K-101.55%-1.24M-625K
Net issuance payments of debt --0--0--0-200.00%-3.75M--0--0---3.13M---625K---1.25M---625K
Net common stock issuance --0---------600.00%-28K---28K--0-----------4K--0
Net preferred stock issuance --0----------60.14M--0--10.24M----------0--0
Proceeds from stock option exercised by employees -84.15%13K-31.58%13K1,425.00%122K960.00%159K--50K--82K--19K--8K-86.73%15K--0
Net other financing activities -----------140K---343K------------------------
Cash from discontinued financing activities
Financing cash flow -99.87%13K131.60%108.36M97.08%-18K4,633.98%56.18M48.64%-321K--10.33M--46.79M---617K-101.55%-1.24M---625K
Net cash flow
Beginning cash position 48.32%77.23M79.45%16.26M178.79%15.53M20.28%5.57M227.25%17.52M--52.07M--9.06M--5.57M-71.11%4.63M--5.35M
Current changes in cash -5.18%-36.34M41.76%60.97M-78.88%738K960.38%9.96M-1,027.91%-2M---34.55M--43.01M--3.49M108.24%939K--215K
End cash Position 133.38%40.89M48.32%77.23M79.45%16.26M178.79%15.53M178.79%15.53M--17.52M--52.07M--9.06M20.28%5.57M--5.57M
Free cash flow -15.78%-6.25M-121.20%-8.62M-53.36%-8.12M193.56%18.94M-170.13%-11.01M---5.4M--40.64M---5.3M23.44%-20.24M---4.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Heat List
US
Overall
Symbol
Price
% Chg

No Data